These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 6129576

  • 1. [40 years of salazosulfapyridine. Is end in sight?].
    van Hees PA, van Tongeren JH.
    Ned Tijdschr Geneeskd; 1982 Oct 30; 126(44):2014-8. PubMed ID: 6129576
    [No Abstract] [Full Text] [Related]

  • 2. [Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases].
    Allgayer H, Kruis W.
    Dtsch Med Wochenschr; 1985 Nov 22; 110(47):1827-9. PubMed ID: 2866083
    [No Abstract] [Full Text] [Related]

  • 3. [Pulmonary diffusing capacity disorder in nonspecific intestinal inflammations unexplainable by acetylation phenotype or treatment with sulfasalazine].
    Bures J, Horácek J, Tilser P, Fixa B, Komárková O, Tichý M, Zaydlar K, Král B.
    Cas Lek Cesk; 1986 Jul 18; 125(29):905-9. PubMed ID: 2873894
    [No Abstract] [Full Text] [Related]

  • 4. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE, Helmstädter V.
    Dtsch Med Wochenschr; 1986 May 02; 111(18):721-2. PubMed ID: 2870908
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI, Present DH, Rubin PH, Fochios SE.
    J Clin Gastroenterol; 1984 Feb 02; 6(1):27-31. PubMed ID: 6142067
    [Abstract] [Full Text] [Related]

  • 10. [New salazosulfapyridine derivatives. Progress in the treatment of chronic inflammatory diseases of the intestines?].
    Modigliani R, Rambaud JC.
    Gastroenterol Clin Biol; 1987 Apr 02; 11(4):325-32. PubMed ID: 2884162
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Exacerbation of ulcerative colitis and Crohn disease as a phenomenon inherent in the disease].
    Habs M, Schifmann R.
    Dtsch Med Wochenschr; 1986 Jul 11; 111(28-29):1131. PubMed ID: 2874004
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].
    Rubinstein BE.
    Ugeskr Laeger; 1982 Feb 01; 144(5):304-6. PubMed ID: 6122297
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.